Michael Lukesch has recently closed his first financing round for Valanx Biotech. He started right after graduating into his entrepreneurial journey and cleared many obstacles on the way with excellence.
Valanx focuses on a novel approach for protein conjugation. Specific, fast, and cost-effective. The company is operating in lower Austria.
In the most recent episode of beginner's mind, Michael talks about how he brought himself to leap into entrepreneurship, navigating the rollercoaster ride of building a startup, what he learned at top-notch incubation programs like Rebel Bio and early-stage conferences like Biovaria.
More information at
valanx.bio
linktr.ee/soschner
lifescienceget2gether.com
Michael Lukesch has recently closed his first financing round for Valanx Biotech. He started right after graduating into his entrepreneurial journey and cleared many obstacles on the way with excellence.
Valanx focuses on a novel approach for protein conjugation. Specific, fast, and cost-effective. The company is operating in lower Austria.
In the most recent episode of beginner's mind, Michael talks about how he brought himself to leap into entrepreneurship, navigating the rollercoaster ride of building a startup, what he learned at top-notch incubation programs like Rebel Bio and early-stage conferences like Biovaria.
More information at
valanx.bio
linktr.ee/soschner
lifescienceget2gether.com